dofequidar has been researched along with Carcinoma, Epidermoid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nishimura, T; Tatsumi, M; Tsuruo, T | 1 |
1 other study(ies) available for dofequidar and Carcinoma, Epidermoid
Article | Year |
---|---|
Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression; Genes, MDR; Humans; KB Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tissue Distribution | 2002 |